To the Editor: The systematic review of the effects of omega-3 fatty acids on cancer risk by Dr MacLean and colleagues1 concluded that dietary supplementation with omega-3 fatty acids is unlikely to prevent cancer. We would like to raise some of our concerns about this review.
Thirty-eight prospective studies were selected for review based on prespecified criteria. However, none of these studies measured fatty acid composition in patients. The food frequency questionnaire and dietary records correlate poorly with direct measurements of fatty acids in patient samples2 and are prone to measurement error.3 Ultimately, the effect of omega-3 fatty acids depends on levels achieved in individuals. Fish cannot synthesize omega-3 fatty acids de novo but rather ingest eicosapentaenoic and docosahexaenoic acid present in phytoplankton and zooplankton.4 Thus, some fish (especially farm-raised fish) are poor sources of omega-3 fatty acids. We therefore think that a more accurate conclusion of this study is that a preventive effect of omega-3 fatty acids on cancers is still uncertain.
We also disagree with the authors on their assessment that animal studies “do not come close to replicating human exposures.” Animal models, especially those developed recently, can closely mimic the clinical course of cancer progression, and are invaluable tools for mechanistic studies that cannot be performed in humans.5 - 6 Animal diets are designed with varying ratios of omega-3 to omega-6 fatty acids, both of which are essential fatty acids required for mammals to survive. It is the ratio of omega-3 to omega-6 that is important for deducing their mechanistic functions, and animal diets have been formulated to reflect human consumption.
Financial Disclosures: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.